Activity of N-methyl-.alpha.- and -.beta.-funaltrexamine at opioid receptors
- 1 August 1986
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 29 (8) , 1551-1553
- https://doi.org/10.1021/jm00158a043
Abstract
The N-methyl analogues (2a, 2b) of the nonequilibrium .mu. opioid receptor antagonist .beta.-funaltrexamine (1b) were synthesized and evaluated in the guinea pig ileum preparation (GPI). These analogues are highly potent, reversible opioid agonists and posses no nonequilibrium antagonist activity. The ineffectiveness of 2b in protecting against irreversible blockage of .mu. opioid receptors by 1b and the fivefold lower reactivity of 2b with cysteine suggest that N-methyl substitution adversely affects both the first and second recognition steps that are essential for effective covalent blockage of opioid receptors.This publication has 4 references indexed in Scilit:
- Crystal structures of .alpha.- and .beta.-funaltrexamine: conformational requirement of the fumaramate moiety in the irreversible blockage of .mu. opioid receptorsJournal of Medicinal Chemistry, 1986
- Importance of carbon 6 chirality in conferring irreversible opioid antagonism to naltrexone-derived affinity labelsJournal of Medicinal Chemistry, 1983
- Stereochemical studies on medicinal agents. 23. Synthesis and biological evaluation of 6-amino derivatives of naloxone and naltrexoneJournal of Medicinal Chemistry, 1977
- STIMULANT ACTIONS OF VOLATILE ANAESTHETICS ON SMOOTH MUSCLEBritish Journal of Pharmacology and Chemotherapy, 1964